Skip to content

Effect of nalbuphine combined with ropivacaine transversal plane block on postoperative and recovery quality in patients with laparoscopic total hysterectomy

Effect of nalbuphine combined with ropivacaine transversal plane block on postoperative and recovery quality in patients with laparoscopic total hysterectomy

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300073472
Enrollment
Unknown
Registered
2023-07-12
Start date
2023-07-12
Completion date
Unknown
Last updated
2023-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative analgesia and recovery quality

Interventions

NR:Bilateral TAP block (20mg Nalbuphine+0.33% Ropivacaine) 60ml mixed solution+2ml of intravenous saline
N:Bilateral TAP block : 0.33% Ropivacaine 60ml+intravenous Nalbuphine 2ml (20mg)
R:Bilateral TAP block 0.33% Ropivacaine 60ml+intravenous injection of normal saline 2ml

Sponsors

The Second Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Selective laparoscopic total hysterectomy 2. Age 18-65 3. BMI 18-30 kg/m ² 4. ASA Level I - III 5. After fully explaining the clinical trial content, voluntarily joining and signing informed consent

Exclusion criteria

Exclusion criteria: 1. Mental or Nervous system disease 2. Allergies to local anesthetics 3. Preoperative Chronic pain 4. Use analgesics or receive psychotherapeutics 5. Puncture site, nearby Skin infection or systemic infection 6. Coagulation dysfunction 7. Severe heart, respiratory, kidney or liver diseases, etc 8. Serious alcoholism (average daily drinking>2 units of alcohol, 1 unit of alcohol=360 ml of beer with 5% alcohol or 45 ml of Baijiu with 40% alcohol or 150 ml of wine)

Design outcomes

Primary

MeasureTime frame
VAS pain score and visceral pain VAS score at rest and activity at 1, 2, 6, 12, 24, and 48 hours after surgery;Postoperative recovery quality score at 24 and 48 hours;

Secondary

MeasureTime frame
The first PCA time and the number of analgesic pump presses within 48 hours after surgery;Accumulated consumption of postoperative analgesics and frequency of remedial analgesia;Duration of nerve block;RAMSAY score for sedation at 1, 2, 6, 12, 24, and 48 hours after surgery;Mean arterial pressure and heart rate at each time point during operation;PACU stay time, first time out of bed, first time exhaust, and postoperative hospitalization time;Postoperative complications such as dizziness, nausea, vomiting, respiratory depression, and skin itching;

Countries

China

Contacts

Public ContactQi Chen

The Second Affiliated Hospital of Anhui Medical University

cq_911@126.com+86 138 6610 3453

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026